{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:09:45Z","timestamp":1790683785855,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12035-014-8733-6","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T09:43:12Z","timestamp":1400060592000},"page":"885-892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Interconnection Between Brain and Retinal Neurodegenerations"],"prefix":"10.1007","volume":"51","author":[{"given":"Vishal","family":"Jindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"8733_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0278-5846(03)00023-X","volume":"27","author":"AG Barber","year":"2003","unstructured":"Barber AG (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283\u2013290","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8733_CR2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diabetes.52.2.506","volume":"52","author":"V Asnaghi","year":"2003","unstructured":"Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M (2003) A role of the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506\u2013511","journal-title":"Diabetes"},{"key":"8733_CR3","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1167\/iovs.03-1392","volume":"45","author":"AM Abu-El-Asar","year":"2004","unstructured":"Abu-El-Asar AM, Dralands L, Missoten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45:2760\u20132766","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"8733_CR5","unstructured":"Alzheimer\u2019s Association (2005) Newest estimate of worldwide prevalence of Alzheimer\u2019s disease = 26.6 million 2006. In: The 2nd Alzheimer\u2019s Association international conference on prevention of dementia, Washington DC"},{"issue":"4","key":"8733_CR6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuroimage.2008.03.050","volume":"41","author":"C Davatzikos","year":"2008","unstructured":"Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM (2008) Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. NeuroImage 41(4):1199\u20131205","journal-title":"NeuroImage"},{"key":"8733_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jcbfm.1991.65","volume":"11","author":"WJ Jagust","year":"1991","unstructured":"Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR et al (1991) Diminished glucose transport in Alzheimer\u2019s disease: dynamic PET studies. J Cereb Blood Flow Metab 11:323\u2013330","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"8733_CR8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.neurobiolaging.2008.02.007","volume":"30","author":"FH Bouwman","year":"2009","unstructured":"Bouwman FH, Schoonenboom NS, Verwey NA, van Elk EJ, Kok A, Blankenstein MA et al (2009) CSF biomarker levels in early and late onset Alzheimer\u2019s disease. Neurobiol Aging 30(12):1895\u20131901","journal-title":"Neurobiol Aging"},{"issue":"3","key":"8733_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15622970701535502","volume":"1\u2013119","author":"BS Diniz","year":"2007","unstructured":"Diniz BS, Pinto JA Jr, Forlenza OV (2007) Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer\u2019s disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry 1\u2013119(3):172\u2013182","journal-title":"World J Biol Psychiatry"},{"key":"8733_CR10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.7973660","volume":"266","author":"LF Scinto","year":"1994","unstructured":"Scinto LF, Daffner KR, Dressler D, Ransil BI, Rentz D, Weintraub S et al (1994) A potential noninvasive neurobiological test for Alzheimer\u2019s disease. Science (New York, NY) 266:1051\u20131054","journal-title":"Science (New York, NY)"},{"key":"8733_CR11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0404.1996.tb07038.x","volume":"94","author":"E Gomez-Tortosa","year":"1996","unstructured":"Gomez-Tortosa E, del Barrio A, Jimenez-Alfaro I (1996) Pupil response to tropicamide in Alzheimer\u2019s disease and other neurodegenerative disorders. Acta Neurol Scand 94:104\u2013109","journal-title":"Acta Neurol Scand"},{"key":"8733_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/exnr.1997.6417","volume":"144","author":"S Higuchi","year":"1997","unstructured":"Higuchi S, Matsushita S, Hasegawa Y, Muramatsu T, Arai H (1997) Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer\u2019s disease, and vascular dementia. Exp Neurol 144:199\u2013201","journal-title":"Exp Neurol"},{"key":"8733_CR13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0197-4580(02)00235-X","volume":"24","author":"A Iijima","year":"2003","unstructured":"Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y (2003) Re-evaluation of tropicamide in the pupillary response test for Alzheimer\u2019s disease. Neurobiol Aging 24:789\u2013796","journal-title":"Neurobiol Aging"},{"key":"8733_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neurobiolaging.2006.10.002","volume":"29","author":"LF Scinto","year":"2008","unstructured":"Scinto LF (2008) Pupillary cholinergic hypersensitivity predicts cognitive decline in community dwelling elders. Neurobiol Aging 29:222\u2013230","journal-title":"Neurobiol Aging"},{"key":"8733_CR15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF03324716","volume":"19","author":"DF Fotiou","year":"2007","unstructured":"Fotiou DF, Brozou CG, Haidich AB, Tsiptsios D, Nakou M, Kabitsi A et al (2007) Pupil reaction to light in Alzheimer\u2019s disease: evaluation of pupil size changes and mobility. Aging Clin Exp Res 19:364\u2013371","journal-title":"Aging Clin Exp Res"},{"key":"8733_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8760(00)00099-4","volume":"37","author":"F Fotiou","year":"2000","unstructured":"Fotiou F, Fountoulakis KN, Tsolaki M, Goulas A, Palikaras A (2000) Changes in pupil reaction to light in Alzheimer\u2019s disease patients: a preliminary report. Int J Psychophysiol 37:111\u2013120","journal-title":"Int J Psychophysiol"},{"key":"8733_CR17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(03)12981-9","volume":"361","author":"LE Goldstein","year":"2003","unstructured":"Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X et al (2003) Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer\u2019s disease. Lancet 361:1258\u20131265","journal-title":"Lancet"},{"key":"8733_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866","journal-title":"Ann Neurol"},{"key":"8733_CR19","unstructured":"Moncaster JA, Moir RD, Mocofanescu A, Burton M, Fu L, Xu W, et al. (2008) In vivo early detection of Alzheimer\u2019s disease-linked ab peptide accumulation in the lens using quasi elastic light scattering ARVO"},{"key":"8733_CR20","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1074\/jbc.271.17.10169","volume":"271","author":"PH Frederikse","year":"1994","unstructured":"Frederikse PH, Garland D, Zigler JS Jr, Piatigorsky J (1994) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271:10169\u201310174","journal-title":"J Biol Chem"},{"key":"8733_CR21","first-page":"179","volume":"9","author":"G Li","year":"2003","unstructured":"Li G, Percontino L, Sun Q, Qazi AS, Frederikse PH (2003) Beta-amyloid secretases and beta-amyloid degrading enzyme expression in lens. Mol Vis 9:179\u2013183","journal-title":"Mol Vis"},{"key":"8733_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9394(87)90001-8","volume":"104","author":"AA Sadun","year":"1987","unstructured":"Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ (1987) Assessment of visual impairment in patients with Alzheimer\u2019s disease. Am J Ophthalmol 104:113\u2013120","journal-title":"Am J Ophthalmol"},{"key":"8733_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0039-6257(89)90127-6","volume":"34","author":"B Katz","year":"1989","unstructured":"Katz B, Rimmer S (1989) Ophthalmologic manifestations of Alzheimer\u2019s disease. Surv Ophthalmol 34:31\u201343","journal-title":"Surv Ophthalmol"},{"key":"8733_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410290110","volume":"29","author":"A Cronin-Golomb","year":"1991","unstructured":"Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS (1991) Visual dysfunction in Alzheimer\u2019s disease: relation to normal aging. Ann Neurol 29:41\u201352","journal-title":"Ann Neurol"},{"key":"8733_CR25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2466\/pms.1996.83.3.987","volume":"83","author":"MF Mendez","year":"1996","unstructured":"Mendez MF, Cherrier MM, Meadows RS (1996) Depth perception in Alzheimer\u2019s disease. Percept Mot Skills 83:987\u2013995","journal-title":"Percept Mot Skills"},{"key":"8733_CR26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med 315:485\u2013487","journal-title":"N Engl J Med"},{"key":"8733_CR27","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1523\/JNEUROSCI.07-11-03416.1987","volume":"7","author":"MS Livingstone","year":"1987","unstructured":"Livingstone MS, Hubel DH (1987) Psychophysical evidence for separate channels for the perception of form, color, movement, and depth. J Neurosci 7:3416\u20133468","journal-title":"J Neurosci"},{"key":"8733_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0733-8619(02)00107-X","volume":"21","author":"GR Jackson","year":"2003","unstructured":"Jackson GR, Owsley C (2003) Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin 21:709\u2013728","journal-title":"Neurol Clin"},{"key":"8733_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0161-6420(90)32621-0","volume":"97","author":"AA Sadun","year":"1990","unstructured":"Sadun AA, Bassi CJ (1990) Optic nerve damage in Alzheimer\u2019s disease. Ophthalmology 97:9\u201317","journal-title":"Ophthalmology"},{"key":"8733_CR30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA (1989) Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res 501:364\u2013372","journal-title":"Brain Res"},{"key":"8733_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17:385\u2013395","journal-title":"Neurobiol Aging"},{"key":"8733_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina. Neurobiol Aging 17:377\u2013384","journal-title":"Neurobiol Aging"},{"key":"8733_CR33","first-page":"24","volume":"36","author":"KU Loffler","year":"1995","unstructured":"Loffler KU, Edward DP, Tso MO (1995) Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci 36:24\u201331","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"8733_CR34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1167\/iovs.08-2384","volume":"50","author":"SE Perez","year":"2009","unstructured":"Perez SE, Lumayag S, Kovacs B, Mufson EJ, Xu S (2009) {beta}-amyloid deposition and functional impairment in the retina of the APPswe\/PS1{Delta}E9 transgenic mouse model of Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 50(2):793\u2013800","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al (1991) Optical coherence tomography. Science (New York, NY) 254:1178\u20131181","journal-title":"Science (New York, NY)"},{"key":"8733_CR36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18\u201324","journal-title":"J Neuroophthalmol"},{"key":"8733_CR37","first-page":"50","volume":"18","author":"V Parisi","year":"2003","unstructured":"Parisi V (2003) Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer\u2019s disease. Semin Ophthalmol 18:50\u201357","journal-title":"Semin Ophthalmol"},{"key":"8733_CR38","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S1388-2457(01)00620-4","volume":"112","author":"V Parisi","year":"2001","unstructured":"Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer\u2019s disease patients. Clin Neurophysiol 112:1860\u20131867","journal-title":"Clin Neurophysiol"},{"key":"8733_CR39","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 48:2285\u20132289","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.410260207","volume":"26","author":"B Katz","year":"1989","unstructured":"Katz B, Rimmer S, Iragui V, Katzman R (1989) Abnormal pattern electroretinogram in Alzheimer\u2019s disease: evidence for retinal ganglion cell degeneration? Ann Neurol 26:221\u2013225","journal-title":"Ann Neurol"},{"key":"8733_CR41","first-page":"483","volume":"55","author":"H Hollander","year":"1996","unstructured":"Hollander H, Bisti S, Maffei L, Hebel R (1996) Electroretinographic responses and retrograde changes of retinal morphology after intracranial optic nerve section. A quantitative analysis in the cat. Exp Brain Res Exp Hirnforsch 55:483\u2013493","journal-title":"Exp Brain Res Exp Hirnforsch"},{"key":"8733_CR42","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/01.wnl.0000244490.07925.8b","volume":"67","author":"HV Danesh-Meyer","year":"2006","unstructured":"Danesh-Meyer HV, Birch H, Ku JY, Carroll S, Gamble G (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67:1852\u20131854","journal-title":"Neurology"},{"key":"8733_CR43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archopht.1991.01080020045040","volume":"109","author":"CS Tsai","year":"1991","unstructured":"Tsai CS, Ritch R, Schwartz B, Lee SS, Miller NR, Chi T et al (1991) Optic nerve head and nerve fiber layer in Alzheimer\u2019s disease. Arch Ophthalmol 109:199\u2013204","journal-title":"Arch Ophthalmol"},{"key":"8733_CR44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","volume":"57","author":"A Ruitenberg","year":"2005","unstructured":"Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A et al (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57:789\u2013794","journal-title":"Ann Neurol"},{"key":"8733_CR45","doi-asserted-by":"crossref","first-page":"13352","DOI":"10.1073\/pnas.0405479101","volume":"101","author":"MF Cordeiro","year":"2004","unstructured":"Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE et al (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A 101:13352\u201313356","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8733_CR46","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.0703707104","volume":"104","author":"L Guo","year":"2007","unstructured":"Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A et al (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A 104:13444\u201313449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8733_CR47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","volume":"133","author":"JE Oliver","year":"2002","unstructured":"Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M et al (2002) Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133:764\u2013772","journal-title":"Am J Ophthalmol"},{"key":"8733_CR48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group T","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group T (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126:487\u2013497","journal-title":"Am J Ophthalmol"},{"key":"8733_CR49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000047976","volume":"47","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Ferrari F, Erb C (2002) High occurrence rate of glaucoma among patients with Alzheimer\u2019s disease. Eur Neurol 47:165\u2013168","journal-title":"Eur Neurol"},{"key":"8733_CR50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F, Maag KP (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol 133:135\u2013137","journal-title":"Am J Ophthalmol"},{"key":"8733_CR51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.02.009","volume":"246","author":"H Tamura","year":"2006","unstructured":"Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K et al (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer\u2019s disease. J Neurol Sci 246:79\u201383","journal-title":"J Neurol Sci"},{"key":"8733_CR52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj\/eye\/6700034","volume":"16","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Ferrari F (2002) Severe progression of glaucomatous optic neuropathy in patients with Alzheimer\u2019s disease. Eye 16:209\u2013212","journal-title":"Eye"},{"key":"8733_CR53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","volume":"49","author":"S Yoneda","year":"2005","unstructured":"Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H (2005) Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol 49:106\u2013108","journal-title":"Jpn J Ophthalmol"},{"key":"8733_CR54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2:605\u2013613","journal-title":"Lancet Neurol"},{"key":"8733_CR55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60:652\u2013656","journal-title":"Neurology"},{"key":"8733_CR56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D et al (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38:643\u2013648","journal-title":"Ann Neurol"},{"key":"8733_CR57","first-page":"1077","volume":"43","author":"SJ McKinnon","year":"2002","unstructured":"McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF et al (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077\u20131087","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i07-185","volume":"43","author":"N Gupta","year":"2008","unstructured":"Gupta N, Fong J, Ang LC, Yucel YH (2008) Retinal tau pathology in human glaucomas. Can J Ophthalmol 43:53\u201360","journal-title":"Can J Ophthalmol"},{"key":"8733_CR59","first-page":"358","volume":"42","author":"ML Crawford","year":"2001","unstructured":"Crawford ML, Harwerth RS, Smith EL 3rd, Mills S, Ewing B (2001) Experimental glaucoma in primates: changes in cytochrome oxidase blobs in V1 cortex. Invest Ophthalmol Vis Sci 42:358\u2013364","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR60","first-page":"1791","volume":"41","author":"ML Crawford","year":"2000","unstructured":"Crawford ML, Harwerth RS, Smith EL 3rd, Shen F, Carter-Dawson L (2000) Glaucoma in primates: cytochrome oxidase reactivity in parvo- and magnocellular pathways. Invest Ophthalmol Vis Sci 41:1791\u20131802","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archopht.118.3.378","volume":"118","author":"YH Yucel","year":"2000","unstructured":"Yucel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN (2000) Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 118:378\u2013384","journal-title":"Arch Ophthalmol"},{"key":"8733_CR62","first-page":"3216","volume":"42","author":"YH Yucel","year":"2001","unstructured":"Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N (2001) Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 42:3216\u20133222","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1350-9462(03)00026-0","volume":"22","author":"YH Yucel","year":"2003","unstructured":"Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N (2003) Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 22:465\u2013481","journal-title":"Prog Retin Eye Res"},{"key":"8733_CR64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1167\/iovs.06-0773","volume":"48","author":"RO Duncan","year":"2007","unstructured":"Duncan RO, Sample PA, Weinreb RN, Bowd C, Zangwill LM (2007) Retinotopic organization of primary visual cortex in glaucoma: a method for comparing cortical function with damage to the optic disk. Invest Ophthalmol Vis Sci 48:733\u2013744","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR65","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Munoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564\u2013572","journal-title":"Arch Ophthalmol"},{"key":"8733_CR66","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","volume":"137","author":"R Klein","year":"2004","unstructured":"Klein R, Peto T, Bird A, Vannewkirk MR (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137:486\u2013495","journal-title":"Am J Ophthalmol"},{"key":"8733_CR67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4419-5635-4_5","volume":"703","author":"JR Sparrow","year":"2010","unstructured":"Sparrow JR (2010) Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv Exp Med Biol 703:63\u201374","journal-title":"Adv Exp Med Biol"},{"key":"8733_CR68","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0196-9781(02)00070-0","volume":"23","author":"CS Atwood","year":"2002","unstructured":"Atwood CS, Martins RN, Smith MA, Perry G (2002) Senile plaque composition and posttranslational modification of amyloidbeta peptide and associated proteins. Peptides 23:1343\u20131350","journal-title":"Peptides"},{"key":"8733_CR69","doi-asserted-by":"crossref","unstructured":"Hoh Kam J, Lenassi E, Jeffery G (2010) Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One 5, doi: 10.1371\/journal.pone.0013127","DOI":"10.1371\/journal.pone.0013127"},{"key":"8733_CR70","first-page":"184","volume":"9","author":"T Dentchev","year":"2003","unstructured":"Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL (2003) Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 9:184\u2013190","journal-title":"Mol Vis"},{"key":"8733_CR71","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer\u2019s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 99:11830\u201311835","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8733_CR72","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1172\/JCI24635","volume":"115","author":"T Yoshida","year":"2005","unstructured":"Yoshida T, Ohno-Matsui K, Ichinose S et al (2005) The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 115:2793\u20132800","journal-title":"J Clin Invest"},{"key":"8733_CR73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9394(14)71036-0","volume":"123","author":"JM Seddon","year":"1997","unstructured":"Seddon JM, Ajani UA, Mitchell BD (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123:199\u2013206","journal-title":"Am J Ophthalmol"},{"key":"8733_CR74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0002-9394(99)80146-9","volume":"125","author":"EH Souied","year":"1998","unstructured":"Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A et al (1998) The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125:353\u2013359","journal-title":"Am J Ophthalmol"},{"key":"8733_CR75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1552-6569.2002.tb00142.x","volume":"12","author":"MO Russ","year":"2002","unstructured":"Russ MO, Cleff U, Lanfermann H, Schalnus R, Enzensberger W, Kleinschmidt A (2002) Functional magnetic resonance imaging in acute unilateral optic neuritis. J Neuroimaging 12:339\u2013350","journal-title":"J Neuroimaging"},{"key":"8733_CR76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/301901","volume":"63","author":"CC Klaver","year":"1998","unstructured":"Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE et al (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63:200\u2013206","journal-title":"Am J Hum Genet"},{"key":"8733_CR77","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1167\/iovs.03-1121","volume":"45","author":"PN Baird","year":"2004","unstructured":"Baird PN, Guida E, Chu DT, Vu HT, Guymer RH (2004) The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45:1311\u20131315","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8733_CR78","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1582-4934.2007.00130.x","volume":"11","author":"A Cedazo-Minguez","year":"2007","unstructured":"Cedazo-Minguez A, Apolipoprotein E (2007) Alzheimer\u2019s disease: molecular mechanisms and therapeutic opportunities. J Cell Mol Med 11:1227\u20131238","journal-title":"J Cell Mol Med"},{"key":"8733_CR79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2005.10.048","volume":"113","author":"TY Wong","year":"2006","unstructured":"Wong TY, Shankar A, Klein R et al (2006) Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Riskin Communities Study. Ophthalmology 113:255\u2013259","journal-title":"Ophthalmology"},{"key":"8733_CR80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","volume":"29","author":"DH Anderson","year":"2010","unstructured":"Anderson DH, Radeke MJ, Gallo NB et al (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29:95\u2013112","journal-title":"Prog Retin Eye Res"},{"key":"8733_CR81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421\u2013424","journal-title":"Science"},{"key":"8733_CR82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/exer.2001.1094","volume":"73","author":"LV Johnson","year":"2001","unstructured":"Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73:887\u2013896","journal-title":"Exp Eye Res"},{"key":"8733_CR83","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"RF Mullins","year":"2000","unstructured":"Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835\u2013846","journal-title":"FASEB J"},{"key":"8733_CR84","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1096\/fj.04-3525fje","volume":"19","author":"S Umeda","year":"2005","unstructured":"Umeda S, Suzuki MT, Okamoto H et al (2005) Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J 19:1683\u20131685","journal-title":"FASEB J"},{"key":"8733_CR85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","volume":"57","author":"P Eikelenboom","year":"1982","unstructured":"Eikelenboom P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol 57:239\u2013242","journal-title":"Acta Neuropathol"},{"key":"8733_CR86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(98)00346-1","volume":"796","author":"Y Shen","year":"1998","unstructured":"Shen Y, Sullivan T, Lee CM, Meri S, Shiosaki K, Lin CW (1998) Induced expression of neuronal membrane attack complex and cell death by Alzheimer\u2019s beta-amyloid peptide. Brain Res 796:187\u2013197","journal-title":"Brain Res"},{"key":"8733_CR87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-328X(00)00149-2","volume":"81","author":"R Strohmeyer","year":"2000","unstructured":"Strohmeyer R, Shen Y, Rogers J (2000) Detection of complement alternative pathway mRNA and proteins in the Alzheimer\u2019s disease brain. Brain Res Mol Brain Res 81:7\u201318","journal-title":"Brain Res Mol Brain Res"},{"key":"8733_CR88","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","volume":"154","author":"K Yasojima","year":"1999","unstructured":"Yasojima K, Schwab C, McGeer EG, McGeer PL (1999) Up-regulated production and activation of the complement system in Alzheimer\u2019s disease brain. Am J Pathol 154:927\u2013936","journal-title":"Am J Pathol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8733-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8733-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8733-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T12:44:09Z","timestamp":1565441049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8733-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["8733"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8733-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}